Acne Vulgaris Acne
Conditions
Interventions
Topical application of bacteriophage gel on the affected area twice a day for 84 days
D000071059
Sponsors
Tsuruta Daisuke
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Patients diagnosed with acne vulgaris 2)One or more acne vulgaris skin rashes (noninflammatory or inflammatory) 3)12 years old over (Both of male and female) 4)Written informed consent by his or her own will
Exclusion criteria
Exclusion criteria: 1) Abnormal skin findings (e.g., erosions, ulcers, etc.) at the site of topical application of the study drug that are judged by the principal investigator or subinvestigator to preclude topical application of the study drug 2) Plans for excessive sun exposure or artificial tanning (e.g., esthetic salon) 3) Ineligible to participate in this clinical study due to participation in other clinical trials or clinical studies 4) Has a history of hypersensitivity (e.g., contact dermatitis) to the study drug or its components 5) Pregnant, possibly pregnant or breast feeding and hope to get pregnant during this study 6)The physicians consider that the patients are inappropriate for this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of adverse event | — |
Secondary
| Measure | Time frame |
|---|---|
| (1) Total number of skin rashes (2) Number of non-inflammatory skin rashes (3) Number of inflammatory skin rashes (4) VAS (subject satisfaction) (5) Number of times of topical application of the study drug and the amount of topical application | — |
Contacts
Public ContactChiharu Tateishi
Osaka Metropolitan University Hospital
Outcome results
None listed